摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

<35S>methanesulfonyl chloride | 40477-82-5

中文名称
——
中文别名
——
英文名称
<35S>methanesulfonyl chloride
英文别名
methane<35S>sulfonyl chloride;methane [35S]sulfonyl chloride;[35S]methanesulfonyl chloride;methane[(35)S]sulfonyl chloride;(35S)-methanesulfonyl chloride;[35S]mesyl chloride;methane(35S)sulfonyl chloride
<35S>methanesulfonyl chloride化学式
CAS
40477-82-5
化学式
CH3ClO2S
mdl
——
分子量
117.487
InChiKey
QARBMVPHQWIHKH-KHWXYDKHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    5
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    <35S>methanesulfonyl chloride 作用下, 以 二氯甲烷 为溶剂, 反应 1.5h, 生成 [35S]methanesulfonamide
    参考文献:
    名称:
    Synthesis of acyl[35S]sulfonamides: Coupling of high specific activity [35S]methane sulfonamide with acids and acid chlorides
    摘要:
    将由[35S]甲磺酰氯和氨生成的高活性[35S]甲磺酰胺与酸和酸性氯化物直接偶联,可获得相应的[35S]酰基磺酰胺,产率极高。制备出的高特异活性[35S]酰基磺酰胺含有可通过碳-碳或碳-氮键形成反应进一步发展的功能性。
    DOI:
    10.1002/jlcr.2974
  • 作为产物:
    描述:
    sodium (35S)-methanesulfonate 在 草酰氯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 <35S>methanesulfonyl chloride
    参考文献:
    名称:
    Jones, Brian P.; Schildknegt, Klaas; Wright, Kathyrn F., Heterocycles, 2000, vol. 53, # 8, p. 1713 - 1724
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis of sulfur-35 reagents for protein labeling
    作者:Sumei Ren、Paul McNamara、David Koharski、David Hesk、Scott Borges
    DOI:10.1002/jlcr.1163
    日期:2007.4
    Two 35S reagents were developed to radiolabel proteins. The first reagent, a N-hydroxysuccinimide (NHS) ester (SMSB), acylates the ε-amino group of lysine residues in proteins. The second reagent, an aldehyde (MSAPPA), labels lysine residues via reductive alkylation. Comparing the two methods, the reductive alkylation method labeled proteins over a broader pH range with higher overall radiochemical yield. The biological activity of the proteins did not change after labeling with these 35S reagents. Copyright © 2007 John Wiley & Sons, Ltd.
    开发了两种35S试剂用于放射性标记蛋白质。第一种试剂是N-羟基琥珀酰亚胺(NHS)酯(SMSB),能够酰化蛋白质中的赖氨酸残基的ε-氨基群。第二种试剂是一种醛(MSAPPA),通过还原烷基化对赖氨酸残基进行标记。比较这两种方法,发现还原烷基化法在更广泛的pH范围内标记蛋白质,并且具有更高的整体放射化学产率。用这些35S试剂标记后,蛋白质的生物活性没有发生变化。版权 © 2007 John Wiley & Sons, Ltd.
  • Design and synthesis of sulfur-35 agents and their applications for protein labeling
    作者:Sumei Ren、Paul McNamara、David Koharski、David Hesk、Scott Borges
    DOI:10.1002/jlcr.1606
    日期:2009.6.30
    Two new 35S reagents were developed to radiolabel proteins. The first reagent, N-succinimidyl-4-(methane [35S]sulfonylamino-methyl)-benzoate (SMSB), acylates the ε-amino group of lysine residues in proteins. The second reagent, 4-(methane [35S]sulfonylamino-methyl)-phenylpropylaldehyde (MSAPPA), labels lysine residues via reductive alkylation. Comparing the two methods, the reductive alkylation method labeled proteins over a broader pH range with higher overall radiochemical yield. More than ten monoclonal antibodies (mAbs) have been labeled with these 35S labeling reagents, the biological activity of the mAbs was unchanged. Part of this work was presented in the Ninth International Symposium on the Synthesis and Applications of Isotopically Labelled Compounds, Edinburgh, 16–20 July 2006. Copyright © 2009 John Wiley & Sons, Ltd.
    开发了两种新的35S试剂用于放射标记蛋白质。第一种试剂是N-琥珀酰亚胺-4-(甲烷[35S]磺酰氨基甲基)苯甲酸(SMSB),它对蛋白质中的赖氨酸残基的ε-氨基进行酰化。第二种试剂是4-(甲烷[35S]磺酰氨基甲基)苯基丙醛(MSAPPA),它通过还原性烷基化对赖氨酸残基进行标记。比较这两种方法时,还原性烷基化方法在更广泛的pH范围内标记蛋白质,且总体放射化学产率更高。已有超过十种单克隆抗体(mAbs)被这些35S标记试剂标记,且mAbs的生物活性未发生改变。部分研究成果在2006年7月16日至20日于爱丁堡举行的第九届同位素标记化合物的合成与应用国际研讨会上进行了展示。版权 © 2009 John Wiley & Sons, Ltd.
  • Anti-hypercholesterolemic compounds
    申请人:Goulet T. Mark
    公开号:US20050267049A1
    公开(公告)日:2005-12-01
    This invention provides cholesterol absorption inhibitors of Formula I: and the pharmaceutically acceptable salts and esters thereof. The compounds are useful for lowering plasma cholesterol levels, particularly LDL cholesterol, and for treating and preventing atherosclerosis and atherosclerotic disease events.
    这项发明提供了化学式I的胆固醇吸收抑制剂,以及其药用可接受的盐和酯。这些化合物有助于降低血浆胆固醇水平,特别是LDL胆固醇,并用于治疗和预防动脉粥样硬化和动脉粥样硬化疾病事件。
  • 10th international symposium on the synthesis and applications of isotopes and isotopically labelled compounds - poster presentations Session 19, Sunday, June 14 to Thursday, June 18, 2009
    作者:William Wheeler
    DOI:10.1002/jlcr.1776
    日期:——
    The poster session is a series of papers dealing with a conglomeration of all of the previous sessions. Cristian Postolache, the fourth of the Wiley Young Scientist Award winners gave a Poster in this session. Copyright © 2010 John Wiley & Sons, Ltd.
    海报展示环节是一系列与之前所有会议相关的论文。Wiley青年科学家奖获奖者之一Cristian Postolache在此次会议中展示了海报。版权所有 © 2010 John Wiley & Sons, Ltd.
  • [EN] SULFONYL SUBSTITUTED N-(BIARYLMETHYL) AMINOCYCLOPROPANECARBOXAMIDES<br/>[FR] N-(BIARYLMETHYLE) AMINOCYCLOPROPANECARBOXAMIDES A SUBSTITUTION SULFONYLE
    申请人:MERCK & CO INC
    公开号:WO2005016886A1
    公开(公告)日:2005-02-24
    N-(Sulfonyloxybiarylmethyl) aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
    N-(磺酰氧基联苯甲基)氨基环丙烷羧酰胺衍生物是布雷金肽B1拮抗剂或逆向激动剂,可用于治疗或预防与布雷金肽B1途径相关的疼痛和炎症症状。
查看更多